✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
首页 › 产品目录 › 盐酸右雷佐生

盐酸右雷佐生

CAS 149003-01-0C11H17ClN4O4MW 304.73

盐酸右雷佐生(CAS 149003-01-0):分子式 C11H17ClN4O4、分子量 304.73。

产品概览

CAS号149003-01-0
分子式C11H17ClN4O4
分子量304.73
应用领域Uses: For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg、m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines.

应用领域

登记用途:Uses: For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg、m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines.。

技术档案

这个产品是什么

盐酸右雷佐生 是一种化工化合物,登记 CAS 号为 149003-01-0,分子式 C11H17ClN4O4(分子量 304.73)。

识别信息

登记 CAS 号:149003-01-0

其分子式 C11H17ClN4O4 由 11 个碳、17 个氢、1 个氯、4 个氮、4 个氧 组成。

别名/同义词:盐酸右雷佐生 · Dexrazoxane hydrochloride

常见问题

盐酸右雷佐生 的 CAS 号是多少?

盐酸右雷佐生 的 CAS 登记号为 149003-01-0。

盐酸右雷佐生 的分子式与分子量是多少?

分子式 C11H17ClN4O4,分子量 304.73。

盐酸右雷佐生 还有哪些别名?

别名/同义词:盐酸右雷佐生、Dexrazoxane hydrochloride。

盐酸右雷佐生 的登记用途是什么?

登记用途:Uses: For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg、m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines.。

PubChem 公开数据

盐酸右雷佐生(CAS 149003-01-0)的独立参考数据,整理自公开化学数据库。

各数据库的登记标识

CAS Registry Number149003-01-0
PubChem CID6918223
Molecular formulaC11H17ClN4O4
IUPAC name4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione;hydrochloride
UNII (FDA)5346058Q7S

计算分子描述符

Molecular Weight304.73
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass304.0938327
Monoisotopic Mass304.0938327
Topological Polar Surface Area98.8
Heavy Atom Count20

在册的记载用途

    For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg/m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines.Breast Feeding; Lactation; Antineoplastic Agents; Cardioprotectants; Cardiotonic Agents; Enzyme Inhibitors; Topoisomerase II Inhibitors

    同义词与商品名

    Dexrazoxane hydrochloride; 149003-01-0; Dexrazoxane HCl; Cardioxane; Totect; Cardioxan; Savene; 1263283-43-7; ADR-529 hydrochloride; ICRF-187 hydrochloride; (+)-Razoxane hydrochloride; Razoxane hydrochloride, (S)-; 2,6-Piperazinedione, 4,4'-((1S)-1-methyl-1,2-ethanediyl)bis-, hydrochloride (1:1); 5346058Q7S; Razoxane (+)-form hydrochloride; DTXSID60164152

    公开数据库对它的描述

    Dexrazoxane hydrochloride · CAS 149003-01-0 · C11H17ClN4O4. UNII 5346058Q7S.

    数据来源:PubChem / Wikidata;与随货 COA 不一致时以 COA 为准。

获取报价

✉ info@591daili.com☎ +86-18553102138📞 WhatsApp邮件询价WhatsApp 询价

供应商:济南圣和化工有限公司

English page: Dexrazoxane hydrochloride

鲁ICP备19031700号-2